NIAGEN BIOSCIENCE, INC. Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions
NIAGEN BIOSCIENCE, INC. (NAGE) reported Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions of $100.00 thousand for the 9-month period ending 2016-10-01, per its 10-Q filed 2016-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions · last filed 2016-11-10
- 2016-10-01: Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions 9 month $100.00K.
| Period end | Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions 9 month |
|---|---|
| 2016-10-01 | $100.00K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |